{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:41:10Z","timestamp":1791848470188,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T00:00:00Z","timestamp":1729382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126384","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T06:29:53Z","timestamp":1727159393000},"page":"126384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus"],"prefix":"10.1016","volume":"42","author":[{"given":"Min","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingbo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2024.126384_bb0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2024.126384_bb0010","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl Dent J"},{"key":"10.1016\/j.vaccine.2024.126384_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.virol.2014.11.007","article-title":"RAB1A promotes vaccinia virus replication by facilitating the production of intracellular enveloped virions","volume":"475","author":"Pechenick Jowers","year":"2015","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126384_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"Parker","year":"2007","journal-title":"Future Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126384_bb0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.15585\/mmwr.mm6510a2","article-title":"Use of vaccinia virus smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to Orthopoxviruses - recommendations of the advisory committee on immunization practices (ACIP), 2015","volume":"65","author":"Petersen","year":"2016","journal-title":"Morb Mortal Wkly Rep"},{"issue":"22","key":"10.1016\/j.vaccine.2024.126384_bb0030","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and Monkeypox vaccine, live, nonreplicating) for Preexposure vaccination of persons at risk for occupational exposure to Orthopoxviruses: recommendations of the advisory committee on immunization practices - United States","volume":"71","author":"Rao","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126384_bb0035","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox [J]","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126384_bb0040","doi-asserted-by":"crossref","first-page":"2192815","DOI":"10.1080\/22221751.2023.2192815","article-title":"Rational development of multicomponent mRNA vaccine candidates against mpox","volume":"12","author":"Zhang","year":"2023","journal-title":"Emerging Microbes Infections"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126384_bb0045","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126384_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103458","article-title":"Current state of, prospects for, and obstacles to mRNA vaccine development","volume":"28","author":"Aljabali","year":"2023","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126384_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126384_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1574-6976.2000.tb00532.x","article-title":"Heterologous protein expression in the methylotrophic yeast Pichia pastoris","volume":"24","author":"Cereghino","year":"2000","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126384_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrmicro1087","article-title":"The humanization of N-glycosylation pathways in yeast","volume":"3","author":"Wildt","year":"2005","journal-title":"Nat Rev Microbiol"},{"issue":"50","key":"10.1016\/j.vaccine.2024.126384_bb0070","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.1016\/j.vaccine.2020.10.061","article-title":"Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126384_bb0075","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0931263100","article-title":"Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris","volume":"100","author":"Choi","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2024.126384_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eng.2021.06.012","article-title":"A vaccine based on the receptor-binding domain of the spike protein expressed in Glycoengineered Pichia pastorisTargeting SARS-CoV-2 stimulates neutralizing and protective antibody responses","volume":"13","author":"Liu","year":"2022","journal-title":"Engineering"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126384_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","article-title":"On the calculation of TCID50 for quantitation of virus infectivity","volume":"36","author":"Lei","year":"2021","journal-title":"Virol Sin"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126384_bb0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41422-023-00792-5","article-title":"Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens","volume":"33","author":"Fang","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.vaccine.2024.126384_bb0095","doi-asserted-by":"crossref","first-page":"1203410","DOI":"10.3389\/fimmu.2023.1203410","article-title":"Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge","volume":"14","author":"Tang","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126384_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"7870","key":"10.1016\/j.vaccine.2024.126384_bb0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal Centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126384_bb0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.vaccine.2024.126384_bb0115","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January-October 2003","volume":"294","author":"Casey","year":"2005","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126384_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tim.2011.12.001","article-title":"Outbreaks of human monkeypox after cessation of smallpox vaccination","volume":"20","author":"Reynolds","year":"2012","journal-title":"Trends Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:42:24Z","timestamp":1741887744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24010661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":24,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24010661"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126384","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126384"}}